CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

View:
format_list_bulleted grid_view

08/29/2022

CHEPLAPHARM increases revenue and earnings in the first half of 2022
Press releases
Read more chevron_right

06/01/2022

CHEPLAPHARM strengthens its oncology portfolio
Press releases
Read more chevron_right

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine
Press releases
Read more chevron_right

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well
Press releases
Read more chevron_right

03/21/2022

Significant and sustainable site expansion
Press releases
Read more chevron_right

03/01/2022

CHEPLAPHARM acquires additional oncology drugs
Press releases
Read more chevron_right

02/23/2022

Jens Rothstein hands over his CFO role to Kia Parssanedjad
Press releases
Read more chevron_right

11/19/2021

CHEPLAPHARM continues strong Growth
Archive Press releases
Read more chevron_right

10/13/2021

CHEPLAPHARM signed deal
Press releases
Read more chevron_right

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives
Press releases
Read more chevron_right
Back to top expand_less